Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: A case report and literature review

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 6, 2010, Pages 729-732

  Hsiao, S H ^a   Chen, H H ^a   Chou, C H ^a   Lin, W L ^a   Liu Yeh, P Y ^a   Wu, T J ^b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

cross reactivity; drug hypersensitivity syndrome; neutropenia; teicoplanin; vancomycin

Indexed keywords

CEFTAZIDIME; METRONIDAZOLE; TEICOPLANIN; VANCOMYCIN;

ADULT; ANAMNESIS; ARTICLE; BLOOD CULTURE; BONE INFECTION; CASE REPORT; CERVICAL SPINE; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; HEPATITIS; HUMAN; HYPERSENSITIVITY REACTION; LABORATORY TEST; LYMPHADENOPATHY; NEUTROPENIA; SIDE EFFECT; WHEEZING;

ANTI-BACTERIAL AGENTS; DRUG HYPERSENSITIVITY; FEMALE; FEVER; HUMANS; INFECTION; MIDDLE AGED; NEUTROPENIA; SPINAL DISEASES; TEICOPLANIN; VANCOMYCIN;

EID: 78449280483     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01124.x     Document Type: Article

References (18)

1. Van Bambeke F, Van Laethem Y, Courvalin P, Tulkens PM, (2004) Glycopeptide antibiotics: from conventional molecules to new derivatives. Drugs, 64, 913-936.
2. Wood MJ, (1996) The comparative efficacy and safety of teicoplanin and vancomycin. Journal of Antimicrobial Chemotherapy, 37, 209-222.
3. Farber BF, Moellering RC Jr, (1983) Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrobial Agents and Chemotherapy, 23, 138-141.
4. Morris A, Ward C, (1991) High incidence of vancomycin-associated leucopenia and neutropenia in a cardiothoracic surgical unit. Journal of Infection, 22, 217-223.
5. Pai MP, Mercier RC, Koster SA, (2006) Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy. Annals of Pharmacotherapy, 40, 224-228.
6. Sanche SE, Dust WN, Shevchuk YM, (2000) Vancomycin-induced neutropenia resolves after substitution with teicoplanin. Clinical Infectious Diseases, 31, 824-825.
7. Handfield-Jones SE, Jenkins RE, Whittaker SJ, Besse CP, McGibbon DH, (1993) The anticonvulsant hypersensitivity syndrome. British Journal of Dermatology, 129, 175-177.
8. Perrett CM, McBride SR, (2004) Teicoplanin induced drug hypersensitivity syndrome. BMJ, 328, 1292.
9. Kwon HS, Chang YS, Jeong YY, (2006) A case of hypersensitivity syndrome to both vancomycin and teicoplanin. Journal of Korean Medical Science, 21, 1108-1110.
10. Lye D, Athana E, O'Brien D, (2007) Teicoplanin hypersensitivity syndrome. International Journal of Antimicrobial Agents, 29, 476-478.
11. Tamagawa-Mineoka R, Katoh N, Nara T, Nishimura Y, Yamamoto S, Kishimoto S, (2007) DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6. International Journal of Dermatology, 46, 654-655.
12. Naranjo CA, Busto U, Sellers EM, et al. (1981) A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics, 30, 239-245. (Pubitemid 12149145)
13. Segarra-Newnham M, Tagoff SS, (2004) Probable vancomycin-induced neutropenia. Annals of Pharmacotherapy, 38, 1855-1859.
14. Ghislain P-D, Roujeau J-C, (2002) Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatology Online J, 8, 5.
15. Yazganoglu KD, Ozkaya E, Ergin-Ozcan P, Cakar N, (2005) Vancomycin-induced drug hypersensitivity syndrome. Journal of the European Academy of Dermatology and Venereology, 19, 648-650.
16. Sullivan JR, Shear NH, (2001) The drug hypersensitivity syndrome: what is the pathogenesis? Archives of Dermatology, 137, 357-364.
17. Tennis P, Stern RS, (1997) Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology, 49, 542-546.
18. Descamps V, Valance A, Edlinger C, et al. (2001) Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Archives of Dermatology, 137, 301-304.